Skip to main content
Erschienen in: Osteoporosis International 12/2010

01.12.2010 | Original Article

Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome

verfasst von: C. R. Holroyd, J. H. Davies, P. Taylor, K. Jameson, C. Rivett, C. Cooper, E. M. Dennison

Erschienen in: Osteoporosis International | Ausgabe 12/2010

Einloggen, um Zugang zu erhalten

Abstract

Summary

This study of 22 girls with Turner syndrome (TS) demonstrates a reduction in bone mineral apparent density (BMAD) at the femoral neck along with a reduction in cortical bone density at the radius (with sparing of trabecular bone). These findings may account for the increased fracture risk noted in this population.

Introduction

Increased fracture risk is a feature of TS; however, the reasons for this are unclear. Little is known regarding cortical and trabecular bone mineral density (BMD) in TS. We have addressed this by measurement of volumetric bone mineral density (vBMD) using peripheral quantitative computed tomography (pQCT).

Methods

We studied 22 females with TS and 21 females without TS; mean ages 12.7 and 12.9 years, respectively. Bone mass measurements were made by dual-energy X-ray absorptiometry (DXA) of the lumbar spine and femur and pQCT of the radius. BMAD was calculated from DXA values. We utilized published reference data to generate Z-scores for both populations.

Results

The mean BMAD Z-score at the lumbar spine was not significantly different in individuals with TS compared to the controls. At the femoral neck, individuals with TS had a significantly lower BMAD Z-score compared to the controls (−1.32 vs. −0.14, p = 0.001). At the distal radius, total vBMD Z-score and trabecular vBMD Z-score were not significantly different between the TS group and controls. A significant reduction in cortical vBMD at the proximal radius was noted in the TS group however (−2.58 vs. −1.38, p = 0.02). There was also a trend towards reduced cortical thickness at this site in the TS group (Z-score −2.89 vs. −1.73, p = 0.08).

Discussion

TS is associated with reduced BMAD at the femoral neck; pQCT data suggests that cortical density is reduced with sparing of trabecular bone. This differential of cortical and trabecular BMD may predispose to fracture.
Literatur
1.
Zurück zum Zitat Nielsen J, Wohlert M (1991) Chromosomal abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 87(1):81–83CrossRefPubMed Nielsen J, Wohlert M (1991) Chromosomal abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Hum Genet 87(1):81–83CrossRefPubMed
2.
Zurück zum Zitat Preger L, Steinbach HL, Moskowitz P, Scully AL, Goldberg MB (1968) Roentgenographic abnormalities in phenotypic females with gonadal dysgenesis. A comparison of chromatin positive patients and chromatin negative patients. Am J Roentgenol Radium Ther Nucl Med 104:899–910PubMed Preger L, Steinbach HL, Moskowitz P, Scully AL, Goldberg MB (1968) Roentgenographic abnormalities in phenotypic females with gonadal dysgenesis. A comparison of chromatin positive patients and chromatin negative patients. Am J Roentgenol Radium Ther Nucl Med 104:899–910PubMed
3.
Zurück zum Zitat Rochiccioli P, David M, Malpuech G, Colle M, Limal JM, Batin J et al (1994) Study of final height in Turner’s syndrome: ethnic and genetic influences. Acta Paediatr 83:305–308CrossRefPubMed Rochiccioli P, David M, Malpuech G, Colle M, Limal JM, Batin J et al (1994) Study of final height in Turner’s syndrome: ethnic and genetic influences. Acta Paediatr 83:305–308CrossRefPubMed
4.
Zurück zum Zitat Stephure DK, Canadian Growth Hormone Advisory Committee (2005) Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomised controlled trial. J Clin Endocrinol Metab 90(6):3360–3366CrossRefPubMed Stephure DK, Canadian Growth Hormone Advisory Committee (2005) Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomised controlled trial. J Clin Endocrinol Metab 90(6):3360–3366CrossRefPubMed
5.
Zurück zum Zitat Saggese G, Baroncelli GI, Bertoelloni S, Barsanti S (1996) The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 81(8):3077–3083CrossRefPubMed Saggese G, Baroncelli GI, Bertoelloni S, Barsanti S (1996) The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 81(8):3077–3083CrossRefPubMed
6.
Zurück zum Zitat Ross JL, Long LM, Feuillan P, Cassoria F, Cutler GB Jr (1991) Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner’s syndrome. J Clin Endocrinol Metab 73(2):355–359CrossRefPubMed Ross JL, Long LM, Feuillan P, Cassoria F, Cutler GB Jr (1991) Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner’s syndrome. J Clin Endocrinol Metab 73(2):355–359CrossRefPubMed
7.
Zurück zum Zitat Gravholt CH, Juul S, Naeraa RW, Hansen J (1998) Morbidity in Turner syndrome. J Clin Epidemiol 51(2):147–158CrossRefPubMed Gravholt CH, Juul S, Naeraa RW, Hansen J (1998) Morbidity in Turner syndrome. J Clin Epidemiol 51(2):147–158CrossRefPubMed
8.
Zurück zum Zitat Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Chrisiansen JS (2003) Increased fracture rates in Turner’s syndrome: a nationwide questionnaire survey. Clin Endocrinol 59(1):89–96CrossRef Gravholt CH, Vestergaard P, Hermann AP, Mosekilde L, Brixen K, Chrisiansen JS (2003) Increased fracture rates in Turner’s syndrome: a nationwide questionnaire survey. Clin Endocrinol 59(1):89–96CrossRef
9.
Zurück zum Zitat Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ (1982) Skeletal demineralisation in Turner’s syndrome. Calcif Tissue Int 34(6):519–522CrossRefPubMed Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ (1982) Skeletal demineralisation in Turner’s syndrome. Calcif Tissue Int 34(6):519–522CrossRefPubMed
10.
Zurück zum Zitat Smith MA, Wilson J, Price WH (1982) Bone demineralisation in patients with Turner’s syndrome. J Med Genet 19:100–103CrossRefPubMed Smith MA, Wilson J, Price WH (1982) Bone demineralisation in patients with Turner’s syndrome. J Med Genet 19:100–103CrossRefPubMed
11.
Zurück zum Zitat Shaw NJ, Rehan VK, Husain S, Marshall T, Smith CS (1997) Bone mineral density in Turner’s syndrome—a longitudinal study. Clin Endocrinol (Oxf) 47:367–370CrossRef Shaw NJ, Rehan VK, Husain S, Marshall T, Smith CS (1997) Bone mineral density in Turner’s syndrome—a longitudinal study. Clin Endocrinol (Oxf) 47:367–370CrossRef
12.
Zurück zum Zitat Neely EK, Marcus R, Rosenfeld RG, Bachrach LK (1993) Turner syndrome adolescents receiving growth hormone and not osteopenic. J Clin Endocrinol Metab 76(4):861–866CrossRefPubMed Neely EK, Marcus R, Rosenfeld RG, Bachrach LK (1993) Turner syndrome adolescents receiving growth hormone and not osteopenic. J Clin Endocrinol Metab 76(4):861–866CrossRefPubMed
13.
Zurück zum Zitat Finby N, Archibold RM (1963) Skeletal abnormalities associated with gonadal dysgenesis. Am J Roentgenol Radium Ther Nucl Med 89:1222–1235PubMed Finby N, Archibold RM (1963) Skeletal abnormalities associated with gonadal dysgenesis. Am J Roentgenol Radium Ther Nucl Med 89:1222–1235PubMed
14.
Zurück zum Zitat Tanner JM (1962) Growth at adolescence, 2nd edn. Blackwell, London Tanner JM (1962) Growth at adolescence, 2nd edn. Blackwell, London
15.
Zurück zum Zitat Carter DR, Bouxsein ML, Marcus R (1992) New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137–145CrossRefPubMed Carter DR, Bouxsein ML, Marcus R (1992) New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7:137–145CrossRefPubMed
16.
Zurück zum Zitat Ashby RL, Ward KA, Roberts SA, Edwards L, Mughal MZ, Adams JE (2009) A reference database for the Stratec XCT-2000 peripheral quantitative computed tomography (pQCT) scanner in healthy children and young adults 6–19 years. Osteoporos Int 20(8):1337–1346CrossRefPubMed Ashby RL, Ward KA, Roberts SA, Edwards L, Mughal MZ, Adams JE (2009) A reference database for the Stratec XCT-2000 peripheral quantitative computed tomography (pQCT) scanner in healthy children and young adults 6–19 years. Osteoporos Int 20(8):1337–1346CrossRefPubMed
17.
Zurück zum Zitat Rauch F, Schonau E (2005) Peripheral quantitative computed tomography of the distal radius in young subjects—new reference data and interpretation of results. J Musculoskelet Neuronal Interact 5(2):119–126PubMed Rauch F, Schonau E (2005) Peripheral quantitative computed tomography of the distal radius in young subjects—new reference data and interpretation of results. J Musculoskelet Neuronal Interact 5(2):119–126PubMed
18.
Zurück zum Zitat Schoenau E, Neu CM, Rauch F, Manz F (2002) Gender-specific pubertal changes in volumetric cortical bone mineral density at the proximal radius. Bone 31(1):110–113CrossRefPubMed Schoenau E, Neu CM, Rauch F, Manz F (2002) Gender-specific pubertal changes in volumetric cortical bone mineral density at the proximal radius. Bone 31(1):110–113CrossRefPubMed
19.
Zurück zum Zitat Bechtold S, Rauch F, Noelle S, Donhauser C, Neu M, Schoenau E, Schwarz HP (2001) Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J Clin Endocrinol Metab 86(12):5819–5823CrossRefPubMed Bechtold S, Rauch F, Noelle S, Donhauser C, Neu M, Schoenau E, Schwarz HP (2001) Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography. J Clin Endocrinol Metab 86(12):5819–5823CrossRefPubMed
20.
Zurück zum Zitat Zuckerman-Levin N, Yaniv I, Schwartz T, Guttmann H, Hochberg Z (2007) Normal DXA bone mineral density but frail cortical bone in Turner’s syndrome. Clin Endocrinol (Oxf) 67:60–64CrossRef Zuckerman-Levin N, Yaniv I, Schwartz T, Guttmann H, Hochberg Z (2007) Normal DXA bone mineral density but frail cortical bone in Turner’s syndrome. Clin Endocrinol (Oxf) 67:60–64CrossRef
21.
Zurück zum Zitat Bakalov VK, Axelrod L, Baron J, Hanton L, Nelson LM, Reynolds JC, Hill S, Troendle J, Bondy CA (2003) Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab 88(12):5717–5722CrossRefPubMed Bakalov VK, Axelrod L, Baron J, Hanton L, Nelson LM, Reynolds JC, Hill S, Troendle J, Bondy CA (2003) Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency. J Clin Endocrinol Metab 88(12):5717–5722CrossRefPubMed
22.
Zurück zum Zitat Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Asarfi A, van Leeuwen W, van Teunenbroek A, van Rijn RR, Drop SL (2001) A longitudinal study on bone mineral density until adulthood in a growth-hormone injection frequency-response trial. Clin Endocrinol 52(5):531–536CrossRef Sas TC, de Muinck Keizer-Schrama SM, Stijnen T, Asarfi A, van Leeuwen W, van Teunenbroek A, van Rijn RR, Drop SL (2001) A longitudinal study on bone mineral density until adulthood in a growth-hormone injection frequency-response trial. Clin Endocrinol 52(5):531–536CrossRef
23.
Zurück zum Zitat Bakalov VK, Van PL, Baron J, Reynolds JC, Bondy CA (2004) Growth hormone therapy and bone mineral density in Turner syndrome. J Clin Endocrinol Metab 89(10):4886–4889CrossRefPubMed Bakalov VK, Van PL, Baron J, Reynolds JC, Bondy CA (2004) Growth hormone therapy and bone mineral density in Turner syndrome. J Clin Endocrinol Metab 89(10):4886–4889CrossRefPubMed
24.
Zurück zum Zitat Suganuma N, Furuhashi M, Hirooka T, Oriwaki T, Hasegawa Y, Mori O, Ogawa M (2003) Bone mineral density in adult patients with Turner’s syndrome: analysis of the effectiveness of GH and ovarian steroid hormone replacement therapies. Endocr J 50(3):263–269CrossRefPubMed Suganuma N, Furuhashi M, Hirooka T, Oriwaki T, Hasegawa Y, Mori O, Ogawa M (2003) Bone mineral density in adult patients with Turner’s syndrome: analysis of the effectiveness of GH and ovarian steroid hormone replacement therapies. Endocr J 50(3):263–269CrossRefPubMed
25.
Zurück zum Zitat Vanderschueren D, Vandenput L, Boonen S et al (2004) Androgens and bone. Endocr Rev 25:389–425CrossRefPubMed Vanderschueren D, Vandenput L, Boonen S et al (2004) Androgens and bone. Endocr Rev 25:389–425CrossRefPubMed
26.
Zurück zum Zitat Wang Q, Alen M, Nicholson PHF et al (2006) Differential effects of sex hormones on peri- and endocortical surfaces in pubertal girls. J Clin Endocrinol Metab 91:277–282CrossRefPubMed Wang Q, Alen M, Nicholson PHF et al (2006) Differential effects of sex hormones on peri- and endocortical surfaces in pubertal girls. J Clin Endocrinol Metab 91:277–282CrossRefPubMed
27.
Zurück zum Zitat Vanderschueren D, Venken K, Ophoff J et al (2006) Clinical review: sex steroids and the periosteum—reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab 91:378–382CrossRefPubMed Vanderschueren D, Venken K, Ophoff J et al (2006) Clinical review: sex steroids and the periosteum—reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab 91:378–382CrossRefPubMed
28.
Zurück zum Zitat Ross JL, Kowal K, Quigley CA, Blum WF, Cutler GB Jr, Crowe B, Hovanes K, Elder FF, Zinn AR (2005) The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr 147(4):499–507CrossRefPubMed Ross JL, Kowal K, Quigley CA, Blum WF, Cutler GB Jr, Crowe B, Hovanes K, Elder FF, Zinn AR (2005) The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr 147(4):499–507CrossRefPubMed
Metadaten
Titel
Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome
verfasst von
C. R. Holroyd
J. H. Davies
P. Taylor
K. Jameson
C. Rivett
C. Cooper
E. M. Dennison
Publikationsdatum
01.12.2010
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 12/2010
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-010-1170-0

Weitere Artikel der Ausgabe 12/2010

Osteoporosis International 12/2010 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.